Abstract
Diseases caused by Chlamydia trachomatis infection and its sequelae represent major public health concerns worldwide. In order to rationally develop an effective vaccine to chlamydial infection, we need a better understanding of the mechanisms underlying the protective and pathological immune responses to chlamydial antigens. Recent studies in chlamydial immunobiology have demonstrated a close link between cytokine production patterns and the type of immune responses to this pathogen. In particular, IL-10 has been found to be associated with susceptibility to chlamydial infection and the typical pathological changes caused by the infection such as granuloma formation and fibrosis. Although Th1 type delayed hypersensitivity (DTH) is associated with protective immunity, the Th2 type DTH documented in interferon (IFN)-γ gene knockout (KO) mice fails to control chlamydial infection. The Th2 type DTH is characterized by eosinophil and neutrophil infiltration and is associated with high levels of IL-4 and IL-5 production. The capability of dendritic cell (DC) in initiating T cell response to Chlamydia has been shown in studies using cultured DCs and a DC line. Further studies should be performed to elucidate the role played by DCs in natural chlamydial infection and the potential involvement of DC subsets in directing immune responses to chlamydial infection.
Keywords: Cytokines, Chlamydia trachomatis, Immunopathology, Protective Immunity, dendritic cell, granuloma formation
Current Pharmaceutical Design
Title: Role of Cytokines in Chlamydia trachomatis Protective Immunity and Immunopathology
Volume: 9 Issue: 1
Author(s): Xi Yang
Affiliation:
Keywords: Cytokines, Chlamydia trachomatis, Immunopathology, Protective Immunity, dendritic cell, granuloma formation
Abstract: Diseases caused by Chlamydia trachomatis infection and its sequelae represent major public health concerns worldwide. In order to rationally develop an effective vaccine to chlamydial infection, we need a better understanding of the mechanisms underlying the protective and pathological immune responses to chlamydial antigens. Recent studies in chlamydial immunobiology have demonstrated a close link between cytokine production patterns and the type of immune responses to this pathogen. In particular, IL-10 has been found to be associated with susceptibility to chlamydial infection and the typical pathological changes caused by the infection such as granuloma formation and fibrosis. Although Th1 type delayed hypersensitivity (DTH) is associated with protective immunity, the Th2 type DTH documented in interferon (IFN)-γ gene knockout (KO) mice fails to control chlamydial infection. The Th2 type DTH is characterized by eosinophil and neutrophil infiltration and is associated with high levels of IL-4 and IL-5 production. The capability of dendritic cell (DC) in initiating T cell response to Chlamydia has been shown in studies using cultured DCs and a DC line. Further studies should be performed to elucidate the role played by DCs in natural chlamydial infection and the potential involvement of DC subsets in directing immune responses to chlamydial infection.
Export Options
About this article
Cite this article as:
Yang Xi, Role of Cytokines in Chlamydia trachomatis Protective Immunity and Immunopathology, Current Pharmaceutical Design 2003; 9 (1) . https://dx.doi.org/10.2174/1381612033392486
DOI https://dx.doi.org/10.2174/1381612033392486 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on Cardiovascular Drug Discovery Is Helicobacter pylori the Infectious Target to Prevent Gastric Cancer? An Interdisciplinary Point of View
Infectious Disorders - Drug Targets Targeting Aldose Reductase for the Treatment of Cancer
Current Cancer Drug Targets Oxidative Stress and Transforming Growth Factor-β<sub>1</sub>-induced Cardiac Fibrosis
Cardiovascular & Hematological Disorders-Drug Targets Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Current Neuropharmacology Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Natural Sesquiterpene Lactones in the Prevention and Treatment of Inflammatory Disorders and cancer: A Systematic Study of this Emerging Therapeutic Approach based on Chemical and Pharmacological Aspect
Letters in Drug Design & Discovery CellSaic, A Cell Aggregate-Like Technology Using Recombinant Peptide Pieces for MSC Transplantation
Current Stem Cell Research & Therapy The Interdisciplinary Management and Safety Perspectives in Endocrine, Metabolic and Psychiatric Disorder
Endocrine, Metabolic & Immune Disorders - Drug Targets Sol - Gel Technique Applied for Biomaterials Achievement
Recent Patents on Materials Science MicroRNA Dysregulation in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Molecular and Genetic Mechanisms of Osteoporosis: Implication for Treatment
Current Molecular Medicine Design and Development of Preservative Free Herbal Dosage Forms
The Natural Products Journal Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential
Current Stem Cell Research & Therapy Protective Effect of Selenium-L-methionine on Radiation-induced Acute Pneumonitis and Lung Fibrosis in Rat
Current Clinical Pharmacology Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Current Hypertension Reviews The Multiple Aspects of Stroke and Stem Cell Therapy
Current Molecular Medicine Drug-Induced Hypokalaemia
Current Drug Safety Generation of Regulatory T Cells to Antigen Expressed in the Retina
Current Immunology Reviews (Discontinued)